期刊文献+

一种新型β_1肾上腺素受体单克隆抗体的制备及其临床应用 被引量:3

A new monoclonal antibody against beta1-adrenergic receptor and its clinical application
下载PDF
导出
摘要 目的:采用杂交瘤细胞融合技术构建特异性针对β_1肾上腺素受体(β_1-AR)细胞外第二环的单克隆抗体(β_1-AAmAb)。方法:设计合成两条肽段,偶联后作为免疫原混合免疫小鼠,挑选免疫反应强的小鼠进行细胞融合。筛选杂交瘤细胞、扩大培养,并于接种小鼠,14d后收集腹水,用Protein G对腹水进行纯化以获得单克隆抗体。结果:ELISA结果显示,杂交瘤细胞上清液中β_1-AA的滴度明显高于对照组(2.9896±0.1873)vs.(0.0635±0.0386),差异有统计学意义(P<0.001)。Western bolt分析发现,β_1-AAmAb与商业化抗β_1-AR多克隆抗体阳性对照具有相同分子量的条带。激光共聚焦结果表明,β_1-AAmAb可与天然存在的β_1-AR相结合。Annexin V/PI流式分析发现,β_1-AAmAb可以诱导心肌细胞发生早期凋亡。乳鼠心肌细胞跳动频率实验证实,β_1-AAmAb与心力衰竭患者血清中的β_1-AA均可增加乳鼠心肌细胞跳动频率。结论:本研究成功构建了与心力衰竭患者血清中存在的β_1-AA具有相同生物学效应的单克隆抗体,使用该单克隆抗体进行后续的研究可以使我们对β_1-AA的致病机制有更好的认识。 Objective: To construct the monoclonal antibody against the extracellular second loop of β_1-adrenergic receptor( β_1-AAmAb),using hybridoma fusion technique. Methods: Blood samples were collected from 18 heart failure patients as well as 10 healthy subjects,and β_1-AA was detected using ELISA. Two peptides were coupled to keyhole limpet hemocyanin( KLH). Mice were immunized with 2 fusion peptides.Splenocytes of immunized mice were fused with myeloma cell line. Positive hybridoma clones were cultivated.Two mice were vaccinated with hybridoma cells secreting β_1-AAmAb. After 14 days,ascitic fluid from immunized mice was collected. Ig Gs were purified via protein G antibody affinity chromatography. Results: Compared to the control,β_1-AA titer was markedly increased in sera of heart failure patients( 0. 643 ± 0. 086) vs.( 0. 155 ± 0. 084,P〈0. 001) and the hybridoma supernatant[( 2. 9896 ± 0. 1873) vs.( 0. 0635 ± 0. 0386,P〈0. 01) respectively. Western blot analysis showed β_1-AAmAb had the same band as commercial anti-β_1-AR polyclonal antibody. Moreover,β_1-AAmAb bonded with native β_1-ARs expressed on cardiomyocytes,and increased cardiomyocyte beat frequency. Annexin V and PI assay demonstrated that β_1-AAmAb induced cardiomyocytes apoptosis. Conclusion: In this study,a monoclonal antibody exerting the same biological effects asβ_1-AAs circulating in patients with heart failure was constructed successfully. Themethod ology provides a reliable strategy for exploring the pathogenesis of β_1-AA.
作者 杜芸辉 李笑 于海存 张诗晗 刘慧荣 DU Yunhui LI Xiao YU Haicun ZHANG Shihan LIU Huirong(Beijing Institute of Heart, Lung and Blood Vessel Disea- ses, Beijing Anzhen Hospital, Capital Medical University,Beijing 100029, China)
出处 《心肺血管病杂志》 2017年第8期696-700,共5页 Journal of Cardiovascular and Pulmonary Diseases
关键词 β_1肾上腺素受体 单克隆抗体 杂交瘤细胞融合 凋亡 β_1-adrenergic receptor Monoclonal antibody Hybridoma Apoptosis
  • 相关文献

参考文献2

二级参考文献32

  • 1Moran AE, Forouzanfar MH, Roth GA, et al. The global burden ofischemic heart disease in 1990 and 2010: the global burden of disease 2010 study. Circulation, 2014, 129: 1493-1501.
  • 2Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: a report from the American heart associa- tion. Circulation, 2014,129 : e28-292.
  • 3Green JJ, Langer R, Anderson DG. A combinatorial polymer li- brary approach yields insight into nonviral gene delivery. Acc Chem Res, 2008,41:749-759.
  • 4Byrne M J, Power JM, Preovolos A, et al. Recireulating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Ther, 2008,15 : 1550-1557.
  • 5Yoshiaki K, Dennis L, Roger JH, MD. Rescuing the failing heart by targeted gene transfer. J Am Coil Cardiol, 2011,57: 1169- 1180.
  • 6Miyamoto MI, del Monte F, Schmidt U, et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A, 2000,97:793-798.
  • 7Kawase Y, Ly HQ, Prunier F, et al. Reversal of cardiac dysfunc- tion after long-term expression of SERCA2a by gene transfer in a preclinical model of heart failure. J Am Coil Cardiol, 2008,51: 1112-1119.
  • 8Hadri L, Bobe R, Kawase Y, et al. SERCA2a gene transfer en- hances eNOS expression and activity in endothelial cells. Mol T- her,2010,18 : 1284-1292.
  • 9Suckau L, Fechner H, Chemaly E, et al. Long-term cardiac-tar- geted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circula- tion,2009, 119: 1241-1252.
  • 10Sakata S, Lebeche D, Sakata N, et al. Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J Mol Cell Cardiol, 2007, 42:852-861.

共引文献15

同被引文献4

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部